IFNB1 and myeloid sarcoma: Furthermore, studies showed that intramuscular administration of IFN-β induced different time-dependent changes in OPG levels, affecting bone homeostasis in MS patients (the levels of OPG protein decreased 25% at the 8 h time point, then increased 43% at the 24 h time point) [54].